{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:09:15Z","timestamp":1793642955616,"version":"4.5.1"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-170"],"award-info":[{"award-number":["P1-170"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cbi.2025.111809","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:49:36Z","timestamp":1762361376000},"page":"111809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Genetic and functional dynamics of Butyrylcholinesterase in Alzheimer's disease: From mechanisms to clinical relevance"],"prefix":"10.1016","volume":"423","author":[{"given":"Uro\u0161","family":"Pre\u0161ern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Goli\u010dnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7922-9745","authenticated-orcid":false,"given":"Aljo\u0161a","family":"Bavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111809_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/bj0370059","article-title":"Studies on cholinesterase: 1. Cholinesterase and pseudo-cholinesterase","volume":"37","author":"Mendel","year":"1943","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2025.111809_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.neuint.2012.06.016","article-title":"Why has butyrylcholinesterase been retained? Structural and functional diversification in a duplicated gene","volume":"61","author":"Johnson","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cbi.2025.111809_bib3","doi-asserted-by":"crossref","first-page":"17083","DOI":"10.1016\/S0021-9258(19)85305-X","article-title":"Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket","volume":"268","author":"Ordentlich","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1139\/y57-148","article-title":"On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers","volume":"35","author":"Kalow","year":"1957","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.cbi.2025.111809_bib5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/med.21745","article-title":"Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer's disease, and fat metabolism","volume":"41","author":"Xing","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cbi.2025.111809_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterases in senile dementia of alzheimer type","volume":"4","author":"Perry","year":"1978","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.cbi.2025.111809_bib7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.410360506","article-title":"Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia","volume":"36","author":"Mesulam","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2025.111809_bib8","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib9","doi-asserted-by":"crossref","first-page":"13270","DOI":"10.1073\/pnas.1817009115","article-title":"Cryo-EM structure of the native butyrylcholinesterase tetramer reveals a dimer of dimers stabilized by a superhelical assembly","volume":"115","author":"Leung","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cbi.2025.111809_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0021-9258(19)75818-9","article-title":"Complete amino acid sequence of human serum cholinesterase","volume":"262","author":"Lockridge","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01633493","article-title":"Isolierung und physikalisch-chemische Charakterisierung der Cholinesterase aus Humanserum","volume":"14","author":"Haupt","year":"1966","journal-title":"Blut"},{"key":"10.1016\/j.cbi.2025.111809_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/138161206775193127","article-title":"The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design","volume":"12","author":"Johnson","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cbi.2025.111809_bib13","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3390\/molecules22122098","article-title":"Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: a crystallographic, kinetic and calorimetric study","volume":"22","author":"Rosenberry","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2025.111809_bib14","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.1016\/S0021-9258(18)45149-6","article-title":"Location of disulfide bonds within the sequence of human serum cholinesterase","volume":"262","author":"Lockridge","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/molecules22071083","article-title":"The C5 variant of the butyrylcholinesterase tetramer includes a noncovalently bound 60 kDa lamellipodin fragment","volume":"22","author":"Schopfer","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2025.111809_bib16","first-page":"258","article-title":"A naturally occurring molecular form of human plasma cholinesterase is an Albumin conjugate","volume":"998","author":"Masson","year":"1989","journal-title":"Biochim Biophys Acta BBA - Protein Struct Mol Enzymol"},{"key":"10.1016\/j.cbi.2025.111809_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0896-6273(01)00584-0","article-title":"PRiMA: the membrane anchor of acetylcholinesterase in the brain","volume":"33","author":"Perrier","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.cbi.2025.111809_bib18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1083\/jcb.144.6.1349","article-title":"Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function","volume":"144","author":"Feng","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cbi.2025.111809_bib19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/2001185a0","article-title":"Evidence for non-allelism between genes affecting human serum cholinesterase","volume":"200","author":"Harris","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2025.111809_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/bi00453a015","article-title":"Structure of the gene for human butyrylcholinesterase. Evidence for a single copy","volume":"29","author":"Arpagaus","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2025.111809_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2025.111809_bib22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/GIM.0b013e3181edef5b","article-title":"Genetic screening in the Persian Jewish community: a pilot study","volume":"12","author":"Kaback","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.cbi.2025.111809_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.gene.2014.11.040","article-title":"The allele frequency of T920C mutation in butyrylcholinesterase gene is high in an Indian population","volume":"555","author":"David","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.cbi.2025.111809_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.fpc.0000197464.37211.77","article-title":"Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the vysya community of India","volume":"16","author":"Manoharan","year":"2006","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.cbi.2025.111809_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1432-1033.1996.00036.x","article-title":"Asp70 in the peripheral anionic site of human butyrylcholinesterase","volume":"235","author":"Masson","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cbi.2025.111809_bib26","doi-asserted-by":"crossref","first-page":"20735","DOI":"10.1016\/S0021-9258(17)45277-X","article-title":"Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations","volume":"265","author":"Neville","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-2952(59)90097-8","article-title":"The activity of various esterase inhibitors towards atypical human serum cholinesterase","volume":"1","author":"Kalow","year":"1959","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111809_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"Abecasis GR. A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2025.111809_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-069X-14-4","article-title":"Butyrylcholinesterase genotype and enzyme activity in relation to gulf war illness: preliminary evidence of gene-exposure interaction from a case\u2013control study of 1991 gulf war veterans","volume":"14","author":"Steele","year":"2015","journal-title":"Environ. Health"},{"key":"10.1016\/j.cbi.2025.111809_bib30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1213\/ANE.0b013e318280a3f3","article-title":"Response to succinylcholine in patients carrying the K-Variant of the butyrylcholinesterase gene","volume":"116","author":"Bretlau","year":"2013","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.cbi.2025.111809_bib31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1471-4159.2000.740869.x","article-title":"The butyrylcholinesterase k\u2010variant shows similar cellular protein turnover and Quaternary interaction to the wild\u2010type enzyme","volume":"74","author":"Altamirano","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2025.111809_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbi.2019.05.007","article-title":"Haplotypes of butyrylcholinesterase K-variant and their influence on the enzyme activity","volume":"307","author":"Jasiecki","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111809_bib33","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1038\/s41598-019-41578-3","article-title":"Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease","volume":"9","author":"Jasiecki","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111809_bib34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cca.2006.11.005","article-title":"A medical health report on individuals with silent butyrylcholinesterase in the vysya community of India","volume":"378","author":"Manoharan","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cbi.2025.111809_bib35","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0041-0101(94)90416-2","article-title":"Tissue distribution of human acetylcholinesterase and butyrylcholinesterase messenger RNA","volume":"32","author":"Jbilo","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.cbi.2025.111809_bib36","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3390\/jcm8111778","article-title":"Serum level and activity of butylcholinesterase: a biomarker for post-stroke dementia","volume":"8","author":"Chen","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cbi.2025.111809_bib37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4149\/BLL_2021_110","article-title":"Serum butyrylcholinesterase activities in patients with non-alcoholic fatty liver disease. Comparison with liver proteosynthetic function and liver fibrosis","volume":"122","author":"Turecky","year":"2021","journal-title":"Bratisl. Med. J."},{"key":"10.1016\/j.cbi.2025.111809_bib38","first-page":"93","article-title":"Comparative methods for the determination of the activity of serumcholinesterases (acylcholin-acyl-hydrolase E.C. 3.1.1.8) and their diagnostical value","volume":"14","author":"Prellwitz","year":"1976","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.cbi.2025.111809_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1625318","article-title":"New views on physiological functions and regulation of butyrylcholinesterase and potential therapeutic interventions","volume":"12","author":"Hajimohammadi","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cbi.2025.111809_bib40","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cercor\/bhx047","article-title":"Variations in acetylcholinesterase activity within human cortical pyramidal neurons across age and cognitive trajectories","volume":"28","author":"Janeczek","year":"2018","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.cbi.2025.111809_bib41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1096-9861(19980413)393:3<374::AID-CNE8>3.0.CO;2-Z","article-title":"Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation","volume":"393","author":"Darvesh","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.cbi.2025.111809_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1471-4159.1986.tb02858.x","article-title":"Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system","volume":"47","author":"Atack","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2025.111809_bib43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0006-3223(90)90524-6","article-title":"Molecular forms of acetylcholinesterase in subcortical areas of normal and alzheimer disease brain","volume":"27","author":"Siek","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cbi.2025.111809_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Sj\u00f6stedt","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cbi.2025.111809_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1083\/jcb.33.1.93","article-title":"The localization of acetylcholinesterase at the autonomic neuromuscular junction","volume":"33","author":"Robinson","year":"1967","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cbi.2025.111809_bib46","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.neurobiolaging.2013.04.027","article-title":"Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease","volume":"34","author":"Darreh-Shori","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2025.111809_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cbi.2025.111809_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cne.10751","article-title":"Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus","volume":"463","author":"Darvesh","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.cbi.2025.111809_bib49","first-page":"52","article-title":"Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene","volume":"58","author":"Primo-Parmo","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cbi.2025.111809_bib50","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.107.133330","article-title":"The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency","volume":"324","author":"Li","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2025.111809_bib51","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1046\/j.1471-4159.2000.751320.x","article-title":"Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse","volume":"75","author":"Li","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2025.111809_bib52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.cbi.2025.111809_bib53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.abb.2009.12.005","article-title":"Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior","volume":"494","author":"Masson","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2025.111809_bib54","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/FPC.0b013e3282f06646","article-title":"Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia","volume":"17","author":"G\u00e4tke","year":"2007","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.cbi.2025.111809_bib55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/FPC.0000000000000221","article-title":"Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene","volume":"26","author":"Wichmann","year":"2016","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.cbi.2025.111809_bib56","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.chroma.2007.02.024","article-title":"Characterization of procaine metabolism as probe for the butyrylcholinesterase enzyme investigation by simultaneous determination of procaine and its metabolite using capillary electrophoresis with electrochemiluminescence detection","volume":"1154","author":"Yuan","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.cbi.2025.111809_bib57","doi-asserted-by":"crossref","first-page":"PL257","DOI":"10.1016\/0024-3205(96)00065-3","article-title":"Cocaine and butyrylcholinesterase (BChE): determination of enzymatic parameters","volume":"58","author":"Mattes","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2025.111809_bib58","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fphar.2018.00112","article-title":"Treating cocaine addiction, obesity, and emotional disorders by viral gene transfer of butyrylcholinesterase","volume":"9","author":"Brimijoin","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111809_bib59","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1210\/en.2004-0569","article-title":"Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites","volume":"145","author":"De Vriese","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2025.111809_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygcen.2015.05.017","article-title":"Pure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin","volume":"224","author":"Schopfer","year":"2015","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.cbi.2025.111809_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jnc.15833","article-title":"Butyrylcholinesterase in lipid metabolism: a new outlook","volume":"168","author":"Gok","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2025.111809_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110680","article-title":"Butyrylcholinesterase and lipid metabolism: possible dual role in metabolic disorders","volume":"383","author":"Furtado-Alle","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111809_bib63","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1210\/en.2016-1166","article-title":"Butyrylcholinesterase deficiency promotes adipose tissue growth and hepatic lipid accumulation in Male mice on high-fat diet","volume":"157","author":"Chen","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2025.111809_bib64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cbi.2008.03.009","article-title":"The butyrylcholinesterase knockout mouse is Obese on a high-fat diet","volume":"175","author":"Li","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111809_bib65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cbi.2016.05.010","article-title":"Potential anti-obesity effects of a long-acting cocaine hydrolase","volume":"259","author":"Zheng","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111809_bib66","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/ijo.2017.123","article-title":"Butyrylcholinesterase regulates central ghrelin signaling and has an impact on food intake and glucose homeostasis","volume":"41","author":"Chen","year":"2017","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.cbi.2025.111809_bib67","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1073\/pnas.1706517114","article-title":"Butyrylcholinesterase gene transfer in obese mice prevents postdieting body weight rebound by suppressing ghrelin signaling","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cbi.2025.111809_bib68","article-title":"Butyrylcholinesterase activity and metabolic syndrome in obese patients","volume":"43","author":"Alc\u00e2ntara","year":"2005","journal-title":"Clin Chem Lab Med CCLM"},{"key":"10.1016\/j.cbi.2025.111809_bib69","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.clinbiochem.2005.04.008","article-title":"Relationship between serum butyrylcholinesterase and the metabolic syndrome","volume":"38","author":"Randell","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cbi.2025.111809_bib70","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/cen.12171","article-title":"Serum butyrylcholinesterase and the risk of future type 2 diabetes: the kansai healthcare study","volume":"80","author":"Sato","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cbi.2025.111809_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2013.05.003","article-title":"2-Arachidonoylglycerol is a substrate for butyrylcholinesterase: a potential mechanism for extracellular endocannabinoid regulation","volume":"536","author":"Barricklow","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2025.111809_bib72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biochi.2022.09.008","article-title":"Novel activity of human BChE: lipid hydrolysis","volume":"204","author":"Gok","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.cbi.2025.111809_bib73","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00109-007-0226-x","article-title":"Cholinergic status modulations in human volunteers under acute inflammation","volume":"85","author":"Ofek","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.cbi.2025.111809_bib74","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF03402177","article-title":"The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation","volume":"9","author":"Pavlov","year":"2003","journal-title":"Mol. Med."},{"key":"10.1016\/j.cbi.2025.111809_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.941467","article-title":"Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer's and Parkinson's disease","volume":"15","author":"Gok","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.cbi.2025.111809_bib76","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/01.WNL.0000068336.84399.9E","article-title":"Butyrylcholinesterase and progression of cognitive deficits in dementia with lewy bodies","volume":"60","author":"Perry","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2025.111809_bib77","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cbi.2010.01.037","article-title":"Butyrylcholinesterase activity in multiple sclerosis neuropathology","volume":"187","author":"Darvesh","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111809_bib78","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5114\/aoms.2016.60760","article-title":"Decreased activity of butyrylcholinesterase in blood plasma of patients with chronic obstructive pulmonary disease","volume":"3","author":"Sicinska","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.cbi.2025.111809_bib79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1515\/labmed-2015-0086","article-title":"Butyrylcholinesterase as an additional marker in the diagnostic network of acute myocardial infarction","volume":"40","author":"Kocaba\u015f","year":"2016","journal-title":"LaboratoriumsMedizin"},{"key":"10.1016\/j.cbi.2025.111809_bib80","doi-asserted-by":"crossref","first-page":"4","DOI":"10.36290\/vnl.2021.027","article-title":"Serum butyrylcholinesterase\/HDL-cholesterol ratio and atherogenic index of plasma in patients with fatty liver disease","volume":"67","author":"Tureck\u00fd","year":"2021","journal-title":"Vnitr. Lek."},{"key":"10.1016\/j.cbi.2025.111809_bib81","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.mayocp.2020.05.048","article-title":"The association between the use of cholinesterase inhibitors and cardiovascular events among older patients with alzheimer disease","volume":"96","author":"Hsiao","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cbi.2025.111809_bib82","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3109\/14767058.2013.795534","article-title":"Butyrylcholinesterase (BChE) activity is associated with the risk of preeclampsia: influence on lipid and lipoprotein metabolism and oxidative stress","volume":"26","author":"Rahimi","year":"2013","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.cbi.2025.111809_bib83","first-page":"157","article-title":"Effect of acetylcholinesterase and butyrylcholinesterase on intrauterine insemination, contribution to inflammations, oxidative stress and antioxidant status; A preliminary report","volume":"17","author":"Haghnazari","year":"2016","journal-title":"J. Reproduction Infertil."},{"key":"10.1016\/j.cbi.2025.111809_bib84","doi-asserted-by":"crossref","DOI":"10.5493\/wjem.v14.i1.87202","article-title":"Emerging significance of butyrylcholinesterase","volume":"14","author":"Sridhar","year":"2024","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.cbi.2025.111809_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1942193","article-title":"A sustained reduction in serum cholinesterase enzyme activity predicts patient outcome following sepsis","volume":"2018","author":"Zivkovic","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cbi.2025.111809_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203128","article-title":"Association between early serum cholinesterase activity and 30-day mortality in sepsis-3 patients: a retrospective cohort study","volume":"13","author":"Peng","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2025.111809_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123948","article-title":"Butyrylcholinesterase predicts cardiac mortality in young patients with acute coronary syndrome","volume":"10","author":"Sulzgruber","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2025.111809_bib88","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3390\/diagnostics12092150","article-title":"Critically ill COVID-19 patients show reduced point of care-measured butyrylcholinesterase activity\u2014A prospective, monocentric observational study","volume":"12","author":"Espeter","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.cbi.2025.111809_bib89","first-page":"1","article-title":"Butyrylcholinesterase levels on admission predict severity and 12-Month mortality in hospitalized AIDS patients","volume":"2018","author":"Xu","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cbi.2025.111809_bib90","article-title":"Serum total cholinesterase activity on admission is associated with disease severity and outcome in patients with traumatic brain injury","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2025.111809_bib91","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.cbi.2025.111809_bib92","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2025.111809_bib93","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s40001-025-02886-9","article-title":"Pathological mechanisms and treatment progression of Alzheimer's disease","volume":"30","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.cbi.2025.111809_bib94","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.52.4.691","article-title":"In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease","volume":"52","author":"Kuhl","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2025.111809_bib95","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0140-6736(96)09124-6","article-title":"Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease","volume":"349","author":"Iyo","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2025.111809_bib96","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(84)90116-8","article-title":"Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in alzheimer's disease","volume":"323","author":"Arendt","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2025.111809_bib97","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0197-0186(92)90189-X","article-title":"Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development\u2014A study of molecular forms","volume":"21","author":"Arendt","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cbi.2025.111809_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in alzheimer's disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.cbi.2025.111809_bib99","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0014-4886(91)90115-S","article-title":"Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation","volume":"112","author":"Vijayan","year":"1991","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cbi.2025.111809_bib100","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","article-title":"Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease","volume":"179","author":"Serrano-Pozo","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cbi.2025.111809_bib101","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/156720512801322546","article-title":"The nun study: risk factors for pathology and clinical-pathologic correlations","volume":"9","author":"Mortimer J","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cbi.2025.111809_bib102","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.cbi.2025.111809_bib103","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2005.08.039","article-title":"Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles","volume":"1060","author":"Eskander","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2025.111809_bib104","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1073\/pnas.90.2.683","article-title":"Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of alzheimer disease","volume":"90","author":"Wright","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cbi.2025.111809_bib105","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/1567205018666210827122704","article-title":"Interaction of exogenous butyrylcholinesterase with \u03b2-Amyloid plaques in 5XFAD\/Butyrylcholinesterase-Knockout mouse brain","volume":"18","author":"Reid","year":"2021","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cbi.2025.111809_bib106","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.0602922103","article-title":"Butyrylcholinesterase attenuates amyloid fibril formation in vitro","volume":"103","author":"Diamant","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cbi.2025.111809_bib107","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000113711","article-title":"Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro","volume":"5","author":"Podoly","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.cbi.2025.111809_bib108","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/jmbi.1997.1245","article-title":"Acetylcholinesterase promotes the aggregation of amyloid-\u03b2-peptide fragments by forming a complex with the growing fibrils 1 1Edited by A. R. Fersht","volume":"272","author":"Alvarez","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cbi.2025.111809_bib109","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1021\/bi0101392","article-title":"A structural motif of acetylcholinesterase that promotes amyloid \u03b2-Peptide fibril formation","volume":"40","author":"De Ferrari","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2025.111809_bib110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-8993(94)91852-X","article-title":"Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients","volume":"640","author":"G\u00f3mez-Ramos","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2025.111809_bib111","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","article-title":"The neuroimmune axis of Alzheimer's disease","volume":"15","author":"Jorfi","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.cbi.2025.111809_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104622","article-title":"The cholinergic anti-inflammatory pathway in humans: state-of-the-art review and future directions","volume":"136","author":"Alen","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.cbi.2025.111809_bib113","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12031-013-0176-4","article-title":"Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease","volume":"53","author":"Shenhar-Tsarfaty","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.cbi.2025.111809_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.115195","article-title":"Dysregulation of butyrylcholinesterase, BCHE gene SNP rs1803274, and pro-inflammatory cytokines in occupational workers","volume":"220","author":"Khan","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.cbi.2025.111809_bib115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jmg.37.3.182","article-title":"Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in northern Ireland","volume":"37","author":"McIlroy","year":"2000","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cbi.2025.111809_bib116","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s004390000277","article-title":"Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease","volume":"106","author":"Lehmann","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.cbi.2025.111809_bib117","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/hmg\/6.11.1933","article-title":"Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed alzheimer's disease","volume":"6","author":"Lehmann","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cbi.2025.111809_bib118","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1096-8628(19990416)88:2<113::AID-AJMG2>3.0.CO;2-3","article-title":"No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease","volume":"88","author":"Ki","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.cbi.2025.111809_bib119","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/hmg\/7.5.937","article-title":"No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease","volume":"7","author":"Singleton","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cbi.2025.111809_bib120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(98)00423-6","article-title":"The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations","volume":"249","author":"Crawford","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2025.111809_bib121","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.12659\/MSM.892982","article-title":"Butyrylcholinesterase K variant and alzheimer's disease risk: a meta-analysis","volume":"21","author":"Wang","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.cbi.2025.111809_bib122","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12883-024-03611-5","article-title":"Onset of alzheimer disease in apolipoprotein \u025b4 carriers is earlier in butyrylcholinesterase K variant carriers","volume":"24","author":"Lane","year":"2024","journal-title":"BMC Neurol."},{"key":"10.1016\/j.cbi.2025.111809_bib123","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3233\/JAD-160373","article-title":"Butyrylcholinesterase K and apolipoprotein E-\u025b4 reduce the age of onset of alzheimer's disease, accelerate cognitive decline, and modulate donepezil response in mild cognitively impaired subjects","volume":"54","author":"De Beaumont","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cbi.2025.111809_bib124","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3233\/JAD-170695","article-title":"Influence of butyrylcholinesterase in progression of mild cognitive impairment to alzheimer's disease","volume":"61","author":"Gabriel","year":"2018","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.cbi.2025.111809_bib125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-191335","article-title":"Interaction between apolipoprotein E and butyrylcholinesterase genes on risk of alzheimer's disease in a prospective cohort study","volume":"75","author":"Chuang","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cbi.2025.111809_bib126","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.2004.039321","article-title":"Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation","volume":"76","author":"Holmes","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cbi.2025.111809_bib127","doi-asserted-by":"crossref","first-page":"17170","DOI":"10.1074\/jbc.M109.004952","article-title":"The butyrylcholinesterase K variant confers structurally derived risks for alzheimer pathology","volume":"284","author":"Podoly","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110783","article-title":"Butyrylcholinesterase signal sequence self-aggregates and enhances amyloid fibril formation in vitro","volume":"386","author":"Jasiecki","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111809_bib129","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","article-title":"Cholinergic system during the progression of Alzheimer's disease: therapeutic implications","volume":"8","author":"Mufson","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.cbi.2025.111809_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2025.111809_bib131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40520-023-02675-6","article-title":"Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer's disease","volume":"36","author":"Zuliani","year":"2024","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.cbi.2025.111809_bib132","first-page":"819","article-title":"Tacrine therapy for the dementia of Alzheimer's disease","volume":"50","author":"Manning","year":"1994","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.cbi.2025.111809_bib133","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fnins.2019.00472","article-title":"Meta-analysis of randomized controlled trials on the efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of alzheimer's disease","volume":"13","author":"Li","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cbi.2025.111809_bib134","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1185\/030079905X56565","article-title":"Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period","volume":"21","author":"Bullock","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.cbi.2025.111809_bib135","article-title":"Evaluating the efficacy and safety of Alzheimer's disease drugs: a meta-analysis and systematic review","volume":"103","author":"Chen","year":"2024","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.cbi.2025.111809_bib136","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2174\/1567205015666180613112040","article-title":"Strategies for continued successful treatment in patients with alzheimer's disease: an overview of switching between pharmacological agents","volume":"15","author":"Blesa","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cbi.2025.111809_bib137","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000501364","article-title":"Efficacy, safety, and tolerability of switching from oral cholinesterase inhibitors to rivastigmine transdermal patch with 1-Step titration in patients with mild to moderate alzheimer's disease: a 24-Week, open-label, multicenter study in Japan","volume":"9","author":"Ueda","year":"2019","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.cbi.2025.111809_bib138","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1017\/S1041610210001985","article-title":"Switching cholinesterase inhibitors in older adults with dementia","volume":"23","author":"Massoud","year":"2011","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.cbi.2025.111809_bib139","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajmg.b.30846","article-title":"Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with donepezil and rivastigmine","volume":"150B","author":"Scacchi","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.cbi.2025.111809_bib140","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-011-1064-x","article-title":"BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors","volume":"67","author":"Chianella","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111809_bib141","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/tpj.2010.61","article-title":"Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease","volume":"11","author":"Patterson","year":"2011","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.cbi.2025.111809_bib142","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000366198","article-title":"Effect of rivastigmine or memantine Add-on therapy is affected by butyrylcholinesterase genotype in patients with probable alzheimer's disease","volume":"73","author":"Han","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.cbi.2025.111809_bib143","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/FPC.0b013e32832f8c17","article-title":"Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment","volume":"19","author":"Ferris","year":"2009","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.cbi.2025.111809_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116569","article-title":"New insights into butyrylcholinesterase: pharmaceutical applications, selective inhibitors and multitarget-directed ligands","volume":"275","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib145","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1021\/acs.jcim.3c00230","article-title":"Identification of potent and selective acetylcholinesterase\/butyrylcholinesterase inhibitors by virtual screening","volume":"63","author":"Xu","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cbi.2025.111809_bib146","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejmech.2016.09.037","article-title":"New azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-Induced neurotoxicity","volume":"125","author":"De Candia","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib147","doi-asserted-by":"crossref","first-page":"28182","DOI":"10.1021\/acsomega.1c04252","article-title":"Halogenated coumarin\u2013chalcones as multifunctional monoamine Oxidase-B and butyrylcholinesterase inhibitors","volume":"6","author":"Rehuman","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.cbi.2025.111809_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113874","article-title":"Inhibition of histone deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: a review (2010\u20132020)","volume":"226","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib149","doi-asserted-by":"crossref","first-page":"17378","DOI":"10.1021\/acs.jmedchem.5c00933","article-title":"Targeting neuroinflammation and cognitive decline: first-in-class dual butyrylcholinesterase and p38\u03b1 mitogen-activated protein kinase inhibitors","volume":"68","author":"Ferjan\u010di\u010d","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118071","article-title":"Discovery of a highly selective BChE inhibitor with concomitant anti-neuroinflammatory activity for treating Alzheimer's disease","volume":"299","author":"Zhao","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112282","article-title":"N-alkylpiperidine carbamates as potential anti-alzheimer\u2019s agents","volume":"197","author":"Ko\u0161ak","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116463","article-title":"Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease","volume":"272","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111809_bib153","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JAD-2006-10108","article-title":"Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental alzheimer therapeutic, bisnorcymserine","volume":"10","author":"Kamal","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cbi.2025.111809_bib154","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11307-021-01584-2","article-title":"Synthesis and initial characterization of a reversible, selective 18F-Labeled radiotracer for human butyrylcholinesterase","volume":"23","author":"Gentzsch","year":"2021","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.cbi.2025.111809_bib155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/cmdc.202000942","article-title":"Synthesis and initial characterization of a selective, pseudo\u2010irreversible inhibitor of human butyrylcholinesterase as PET tracer","volume":"16","author":"Gentzsch","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbi.2025.111809_bib156","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.7150\/thno.54589","article-title":"Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for alzheimer disease","volume":"11","author":"Rejc","year":"2021","journal-title":"Theranostics"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725004399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725004399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:54:09Z","timestamp":1777398849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725004399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":156,"alternative-id":["S0009279725004399"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111809","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and functional dynamics of Butyrylcholinesterase in Alzheimer's disease: From mechanisms to clinical relevance","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111809"}}